Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: A comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography

European Journal of Nuclear Medicine

Volumn 23, Issue 6, 1996, Pages 683-689

  Kuwabara, Yasuo ^a   Ichiya, Yuichi ^a   Sasaki, Masayuki ^a   Akashi, Yuko ^a   Yoshida, Tsuyoshi ^a   Fukumura, Toshimitsu ^a   Masuda, Kouji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Acetazolamide; Cerebral blood flow; Crossed cerebellar diaschisis; Emission computed tomography; Technetium 99m hexamethylpropylene amine oxime

Indexed keywords

ACETAZOLAMIDE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN INFARCTION; CEREBELLUM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSED CEREBELLAR DIASCHISIS; DRUG EFFECT; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASODILATATION;

ACETAZOLAMIDE; ADULT; AGED; CEREBELLUM; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; OXIMES; OXYGEN RADIOISOTOPES; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; WATER;

EID: 0029890365     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00834531     Document Type: Article

References (24)

1. Baron JC, Bousser MG, Comar D, Castaigne P. "Crossed cerebellar diaschisis" in human supratentorial brain infarction [abstract]. Ann Neurol 1980; 8: 128.
2. Pantano P, Baron JO, Samson Y, Bousser MG, Derouesne C, Comar D. Crossed cerebellar diaschisis: further studies. Brain 1986; 109: 677-694.
3. Pedersen E. Effect of acetazolamide on cerebral blood flow in subacute and chronic cerebrovascular disease. Stroke 1987; 18: 887-891.
4. Chollet F, Celsis P, Clanet M, Chaumeil BG, Rascol A, Vergnes JPM. SPECT study of cerebral blood flow reactivity after acetazolamide in patients with transient ischemic attacks. Stroke 1989; 20: 458-464.
5. Lassen NA, Anderson AR, Friberg L, Paulsen OB. The retention of [Tc-99m]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 1988; 8: s13-s22.
6. Ishii K, Kanno I, Uemura K, Hatazawa J, Okudera T, Inugami A, Ogawa T, Fujita H, Shimosegawa E. Comparison of carbon dioxide responsiveness of cerebellar blood flow between affected and unaffected sides with crossed cerebellar diaschisis. Stroke 1994; 25: 826-830.
7. 15O-water. J Cereb Blood Flow Metab 1983; 3: 141-153.
8. 15O autoradiography and positron emission tomography, with respect to the dispersion of the input function. J Cereb Blood Flow Metab 1986; 6: 536-545.
9. Matsuda H, Higashi S, Asli IN, Eftekhari M, Esmaili J, Seki H, Tsuji S, Oba H, Imai K, Terada H, Sumiya H, Hisada K. Evaluation of cerebral collateral circulation by technetium-99m HM-PAO brain SPECT during Matas test: report of three cases. J Nucl Med 1988; 29: 1724-1729.
10. Patronas NJ, Di Chiro D, Smith BH, De La Paz R, Brooks RA, Milan H, Kornblith PL, Bairamian D, Mansi L. Depressed cerebellar glucose metabolism in supratentorial tumors. Brain Res 1984; 291: 93-101.
11. Pappata S, Dinh ST, Baron C, Cambon H, Syrota A. Remote metabolic effects of cerebrovascular lesions: magnetic resonance and positron tomography imaging. Neuroradiology 1987; 29: 1-6.
12. Yamauchi H, Fukuyama H, Kimura J. Hemodynamic and metabolic changes in crossed cerebellar hypoperfusion. Stroke 1992; 23: 855-860.
13. Yamauchi H, Fukuyama H, Kimura J, Ishikawa M, Kikuchi H. Crossed cerebellar hypoperfusion indicates the degree of uncoupling between blood flow and metabolism in major cerebral arterial occlusion. Stroke 1994; 25: 1945-1951.
14. Bogsrud TV, Rootwelt K, Russell D, Nyberg-Hansen R. Acetazolamide effect on cerebellar blood flow in crossed cerebral-cerebellar diaschisis. Stroke 1990; 21: 52-55.
15. Sakashita Y, Matsuda H, Kakuda K, Takamori M. Hypoperfusion and vasoreactivity in the thalamus and cerebellum after stroke. Stroke 1993; 24: 84-87.
16. 99mTc-HMPAO brain SPECT. Clin Nucl Med 1992; 17: 581-586.
17. Terada H, Gomi T, Sasaki K, Murakami S, Sato S, Nagamoto M, Kuwajima A, Hiramatsu Y, Iwabuchi S, Samejima H, Yoshii N. Acetazolamide effect on vascular response in crossed cerebellar diaschisis as measured by 99mTc-HMPAO SPECT. Jpn J Nucl Med 1993; 30: 1075-1080.
18. Gotoh F, Meyer JS, Tomita M. Carbonic anhydrase inhibition and cerebral venous blood gases and ions in man. Arch Intern Med 1966; 117: 39-46.
19. Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 1984; 74: 1634-1639.
20. 2O PET. Stroke 1995; 26: 1825-1829.
21. Murase K, Tanada S, Fujita H, Sakaki S, Hamamoto K. Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT. J Nucl Med 1992; 33: 135-143.
22. Hayashida K, Nishimura T, Imakita S, Uehara T. Validation to eliminate vascular activity on 99Tcm-HMPAO brain SPECT for regional cerebral blood flow (rCBF) determination. Nucl Med Commun 1991; 12: 545-550.
23. Neirinckx RD, Bruke JF, Harrison RC, Forster AM, Anderson AR, Lassen NA. The retention mechanism of technetium-99m-HMPAO: intracellular reaction with glutamate. J Cereb Blood Flow Metab 1988; 8: s4-s12.
24. Anderson AR, Friberg H, Knudsen KBM, Barry DI, Paulson OB, Schmidt JF, Lassen NA, Neirinckx RD. Extraction of [99mTc]-d,l-HMPAO across the blood brain barrier. J Cereb Blood Flow Metabol 1988; 8: s44-s51.